VTX-27
| Code | Size | Price |
|---|
| SYN-1206-M100 | 100 mg | Enquire |
Quantity:
| SYN-1206-M050 | 50 mg | Enquire |
Quantity:
| SYN-1206-M001 | 1 mg | £268.00 |
Quantity:
| SYN-1206-M005 | 5 mg | £701.00 |
Quantity:
| SYN-1206-M010 | 10 mg | £1,123.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
4°C
Documents
Further Information
Alternate Names/Synonyms:
VTX27
Appearance:
Solid.
CAS:
1321924-70-2
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C20H24ClFN6O/c1-11(2)20(3,29)15-10-28(8-7-23-15)19-13(21)9-14(22)17(25-19)16-12-5-4-6-24-18(12)27-26-16/h4-6,9,11,15,23,29H,7-8,10H2,1-3H3,(H,24,26,27)/t15-,20+/m0/s1
InChiKey:
HXWARSZQGAFXJM-MGPUTAFESA-N
Long Description:
Chemical. CAS: 1321924-70-2. Formula: C20H24ClFN6O. MW: 418.9. VTX-27 is a potent and selective inhibitor of the PKCtheta enzyme, with over 1000-fold against classical isoforms and over 10000-fold against atypical isoforms.
Molecular Formula:
C20H24ClFN6O
Molecular Weight:
418.9
Package Type:
Plastic Vial
Product Description:
VTX-27 is a potent and selective inhibitor of the PKCtheta enzyme, with over 1000-fold against classical isoforms and over 10000-fold against atypical isoforms.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 1 year after receipt when stored at +4°C.
References
Design and optimization of selective protein kinase C theta (PKCtheta) inhibitors for the treatment of autoimmune diseases: J.M. Jimenez, et al.; J. Med. Chem. 56, 1799 (2013)
Related Products
| Product Name | Product Code | Supplier | Ingenol-3-angelate | AG-CN2-0012 | AdipoGen Life Sciences | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|